Our three-year vision (2026): Modernize 1,000 ORs for the wireless age.
We pursue success and satisfaction by:
Mr. Eugene Malinskiy is one of our co-founders (est. 2015) and our Chief Executive Officer. Prior to Lazurite, he served as the founder and CEO of DragonID, LLC, a healthcare innovation and engineering consultancy specializing in medical devices for orthopedics and cardiology.
Ms. Leah Brownlee joined our company in her current roles in October 2020. She currently serves as board chair of Switch Automation (US), Inc. and her previous positions include of counsel in the global corporate department at Squire Patton Boggs (US) LLP, a top-20 global law firm and executive vice president of compliance and operations at Cleveland Biolabs (NASDAQ: CBLI).
Mr. Neil Lyons joined our company in June 2023. He started his career with Deloitte and practiced as a CPA with them for more than 10 years. From 2005 to 2021, Neil served as the CFO for three life science companies, two public and one private. Since then, Mr. Lyons has worked with life science companies on a fractional basis.
Mr. Dan Nelson joined our company in his current role in 2018. His previous positions include senior product manager at Volk Optical Inc., project manager at DXY Solutions, LLC, and sergeant in the US Air Force.
Mr. Patrick Polito, a certified quality auditor, joined our company in 2016. His previous positions include manager of client services at iuvo BioScience, microbiologist, and validation specialist. He has spent many years in both client and regulatory agency facing positions.
Ms. Nikki DiFilippo joined Lazurite in 2022. Her expertise in channel development and market analysis has produced a series of successful product launches and steady growth for start-ups and mid-sized companies.
Ms. Julia Greenspan joined the Lazurite team in 2023. She has more than 25 years of industry experience, specializing in orthopedic surgery and sales leadership. She earned her MBA from the University of California, Davis. Greenspan has held positions with Synthes Trauma, Stryker Trauma, and 3M. She also volunteers with Operation Rainbow as a surgical technologist for medical missions in South America.
Dr. Jazrawi is chief of the sports medicine division at NYU Langone Health, as well as the team physician for NYU athletics and Long Island University athletics. He specializes in the surgical management of sports injuries, and has substantial experience in the care of pitchers in particular, and other athletes with injuries due to overhead throwing.
Laith Jazrawi, MD
NYU Langone Health
Dr. Proctor is an orthopaedic surgeon at De La Vina Surgicenter. His previous roles include stadium physician for the New York Yankees, as well as consulting physician for the US Ski Team and UC Santa Barbara athletics. He has developed and patented devices that prevent and rehabilitate sports injuries, and his current research includes novel techniques to repair shoulders and knees.
Christopher Proctor, MD
De La Vina Surgicenter
Dr. Schickendantz is program director of orthopedic surgery for the Cleveland Clinic Sports Health. He is also the head team physician of the Cleveland Guardians. His specialties include sports medicine and arthroscopic surgery of the shoulder and elbow. His memberships include the American Board of Orthopedic Surgery and the MLB Team Physicians Association.
Mark Schickendantz, MD
The Cleveland Clinic
Dr. Voos currently serves as chair of the orthopedics departments at University Hospitals and Case Western Reserve University, which includes overseeing their renowned orthopedic training programs and research divisions. He was recently elected vice president of the NFL® Physicians Society and serves as the team physician for the Cleveland Browns™.
James Voos, MD
University Hospital (CLE)
Mark Froimson, MD
Chair
Gary Cohn
Jeff Hanson
Michael Salerno
Jon Serbousek
Eugene Malinskiy
Co-founder and CEO
We established Lazurite to build operating room technology commensurate with the skills of clinicians, in order to improve patient outcomes, boost clinical safety, and improve healthcare efficiency.
01
People first.
We focus on problems in healthcare (not just the healthcare market). We use science, engineering, and design to build durable, substantial solutions. Our rigorous solutions open opportunities in the market.
02
Be present.
Every interaction with an investor, vendor, or partner represents an opportunity to bolster faith in our vision. We take the time to tell our story well, and build personal connections at every opportunity.
03
Be open. Be receptive.
We recognize the need to think anew about persistent challenges, and to seek out creative connections that spark new ideas on the way to serendipitous solutions.
04
Do what it takes, together.
There is no substitute for hard work—or teamwork. We ask each other difficult questions. We connect the dots together, and we celebrate our triumphs together.
05
Some things are not possible, yet.
Through creativity, diligence, and collaboration, we can narrow the gap between today, when a goal is impossible, and the moment it becomes possible.
06
Reliability equals sustainability.
When we say what we mean and deliver the goods, we ensure that we, as a company, thrive.
We know surgeons.
They are our stakeholders and our inspiration. Where they see inefficiencies, we see opportunities.
We listen, observe, and integrate.
Our team is our foundation. We work diligently and inclusively to identify areas for transformative improvements.
We solve.
Our engineers plan, prototype, test, and repeat. We develop solutions that are as simple as possible, but no simpler.
We influence people.
We deliver value by design to providers and patients. Our mission is to drive better people outcomes.
Our team pursues engineering excellence through its embrace of quality standards. Our quality policy reflects our work philosophy:
Our commitment to quality is reflected by our partners. Our products are designed, manufactured, and tested to ensure that they meet the quality standards the medical device industry demands. We have implemented processes compliant with ISO 13485, the medical industry’s quality management standard. Likewise, we expect our critical partners and manufacturers to also follow ISO 13485 requirements. Lazurite is certified bi-annually by the global certification body NQA.
The road to innovation comes with formidable challenges—technical ones, to be sure, but also legal and ethical challenges. Along this road, shortcuts abound. At Lazurite, though, we remain steadfast in our commitment to legal and ethical conduct. That conduct includes our interactions and transactions with our customers, employees, suppliers, partners, shareholders, community, and competitors.
As part of this commitment, we have adopted the AdvaMed Code of Ethics.
The AdvaMed Code of Ethics provides medical technology companies with guidance on ethical interactions and relationships with healthcare professionals. It offers a blueprint for how to build trust among employees and, in turn, how employees can conduct themselves in a trustworthy manner with one of our key constituencies.
Ethics and integrity are key to establishing and maintaining trust. We know that in medtech, though, the pressure to move fast can strain—or even break—the bonds of trust. At Lazurite, we aim to maintain a standard of open, honest communication. We invite our employees to provide each other with in-person feedback on experimental design, data integrity, and reliable sources for marketing claims, to begin. We remain aware that it’s not easy sometimes to ask the difficult questions. In turn, we partnered with Navex to create the EthicsPoint Lazurite Portal. This third-party portal allows our employees to:
Navex helps organizations build and maintain a resilient, ethical, organizational culture in order to reduce risk and strive for full compliance.